Article Sidebar
Published:
Nov 13, 2020Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Resveratrol protects the retina from I/R injury by inhibiting RGCS apoptosis, glial activation and expression of inflammatory factors
Abstract
Purpose: To study the protective effect of resveratrol against retinal injury induced by ischemiareperfusion (I/R), and the underlying mechanism action.
Methods: Retinal I/R injury was established in 72 healthy male SD rats. The rats were assigned to 3 groups: control, model and resveratrol groups, with 24 rats in each group. Pathological changes in retina were determined using H&E staining. Retinal ganglion cells (RGCs) were counted using
fluorescence gold retrograde staining. Western blotting was used to assay the expressions of caspase- 3, Bax, Bcl-2, GFAP, COX-2 and iNOS. The expressions of COX-2 and iNOS were measured by immunofluorescence.
Results: The retina in the control group was dense and ordered, and its morphology was normal. In contrast, the retina in the model group was thinner, with loose cells and disordered structure. In the resveratrol group, the retina was thicker, the structure was orderly, and the cells were dense. Relative to control, the population of RGCs in model rat retina was significantly reduced, and the expressions of Bcl-2, Bax, caspase-3, GFAP, COX-2 and iNOS were significantly upregulated (p < 0.05). In the resveratrol group, the number of RGCs in the retina was markedly elevated, relative to model rats, and the expressions of Bcl-2, Bax, caspase-3, GFAP, COX-2 and iNOS were significantly decreased (p < 0.05).
Conclusion: Resveratrol protects the retina from I/R injury in rats by inhibiting RGCs apoptosis, glial activation and expressions of inflammatory factors. Thus, this compound may be potentially suitable for the management of retina damage.
Keywords: Resveratrol, RGCs apoptosis, Glial activation, Inflammatory factors, I/R injury
